By: Natasha Archary
The South African Health Products Regulatory Authority (SAHPRA) has confirmed the second death linked to the Johnson & Johnson (J&J) Covid-19 vaccine.
In a statement, the health regulatory authority informed the public of the second fatal case of the rare Guillain-Barré Syndrome (GBS) following the vaccine.
The first death was reported on 04 August, and a causality assessment was conducted by the National Immunisation Safety Expert Committee (NISEC).
SAHPRA says GBS is a very rare but potentially severe neurological adverse event that is associated with the administration of various vaccines and other medicines. According to the health body, GBS can also be triggered by some bacterial or viral infections, including SARS-CoV-2.
Symptoms associated with GBS include muscle weakness, muscle pain, numbness, and tingling. However, health experts say there are known cases where Guillain-Barré Syndrome resolved itself with no serious after-effects.
Regulatory authorities have previously investigated reports of GBS associated with Covid-19 vaccines.
Also read: “Irritating cockroach!” Malema reportedly sues Kenny Kunene for R1 million



